CSIR launches India’s first anti diabetic ayurvedic drug BGR -34
Free Current Affairs to Your Email
Posted on:28 Jun 2016 11:06:20
28 June 2016 Current Affairs: The Council for Scientific and Industrial Research (CSIR) has launched BGR-34, an anti-diabetic ayurvedic drug designed for type 2 Diabetes mellitus.
The anti-diabetic ayurvedic drug BGR-34 has been jointly developedby National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP).
BGR-34 : BGR-34 works by controlling blood sugar and limiting the harmful effects and toxicity of other drugs. It contains 34 identified active phyto-constitutes from herbal resources. It has been economically priced at 5 rupees per tablet as compared to latest DPP4 inhibitors globally.
Council of Scientific and Industrial Research (CSIR) : CSIR is an autonomous body and the largest research and development (R&D) organisation in India. It was established in 1942. It operates as an autonomous body registered under the Registration of Societies Act of 1860.
It is mainly funded by the Union Ministry of Science and Technology. CSIR’s R&D activities include aerospace engineering, ocean sciences, structural engineering, metallurgy, life sciences, chemicals, mining, food, petroleum, leather, and environment.
FreshersLive - No.1 Job site in India. Here you can find latest 2017 government as well as private job recruitment notifications for different posts vacancies in India. Get top company jobs for both fresher and experienced. Job Seekers can get useful interview tips, resume services & interview Question and answer. Practice online test free which is helpful for interview preparation. Register with us to get latest employment news/rojgar samachar notifications. Also get latest free govt and other sarkari naukri job alerts daily through E-mail.